Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01894802 · ClinicalTrials.gov registry record · NA

Cortical Recording and Stimulating Array Brain-Machine Interface

A NA study of Spinal Cord Injury and Tetraplegia, sponsored by Michael Boninger.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT01894802 is a NA study of Spinal Cord Injury and Tetraplegia that is actively recruiting participants, run by Michael Boninger. The registered enrollment target is 30 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01894802, a NA study of Spinal Cord Injury and Tetraplegia, is actively recruiting participants, sponsored by Michael Boninger.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research study is to demonstrate the safety and efficacy of using two CRS Arrays (microelectrodes) for long-term recording of brain motor cortex activity and microstimulation of brain sensory cortex.

Interventions

  • DEVICE Implantation of CRS Arrays

Study Locations (2)

Illinois

  • University of Chicago - Chicago

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-12-01
Est. Completion 2029-12
Phase NA

Sponsor

Michael Boninger

2 total trials

What the Registry Record Tells You About NCT01894802

The ClinicalTrials.gov registry entry for NCT01894802 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (65% lower). The listed sponsor is Michael Boninger, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Implantation of CRS Arrays is the first listed.

NCT01894802 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01894802 about?

NCT01894802 is a clinical study titled "Cortical Recording and Stimulating Array Brain-Machine Interface". The purpose of this research study is to demonstrate the safety and efficacy of using two CRS Arrays (microelectrodes) for long-term recording of brain motor cortex activity and microstimulation of brain sensory cortex.

What is the current status of trial NCT01894802?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2013-12-01. Estimated completion is 2029-12.

What conditions does trial NCT01894802 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Tetraplegia, Brainstem Stroke, Brachial Plexus Injury, Above Elbow Amputation.

What interventions are being tested in trial NCT01894802?

The interventions under investigation include: Implantation of CRS Arrays (DEVICE).

Who is sponsoring clinical trial NCT01894802?

This trial is sponsored by Michael Boninger, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01894802 being conducted?

This trial has 2 study locations across Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.